Damora Therapeutics DMRA SEC Filings

NASDAQ DMRA
$24.15 +0.08 (+0.33%)
At close: Nov 10, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Damora Therapeutics, Inc. (DMRA) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
110-QQuarterly & Annual Report0001193125-26-447162Nov 4, 2026 9:00 PM
24Insider Transaction0001193125-26-403355Sep 28, 2026 11:00 AM
34Insider Transaction0001193125-26-349537Aug 13, 2026 9:00 PM
43Insider Transaction0001193125-26-349515Aug 13, 2026 8:55 PM
5EFFECTOthers9999999995-26-002630Aug 12, 2026 4:15 AM
6S-8 POSProspectus0001193125-26-342737Aug 10, 2026 9:28 PM
7S-8 POSProspectus0001193125-26-342730Aug 10, 2026 9:26 PM
8POSASROthers0001193125-26-342717Aug 10, 2026 9:24 PM
9S-8 POSProspectus0001193125-26-342710Aug 10, 2026 9:22 PM
10S-8 POSProspectus0001193125-26-342698Aug 10, 2026 9:20 PM
11S-8 POSProspectus0001193125-26-342687Aug 10, 2026 9:18 PM
12S-8 POSProspectus0001193125-26-342677Aug 10, 2026 9:16 PM
13S-8 POSProspectus0001193125-26-342672Aug 10, 2026 9:14 PM
14S-8 POSProspectus0001193125-26-342663Aug 10, 2026 9:12 PM
15POS AMOthers0001193125-26-342562Aug 10, 2026 8:45 PM
168-A12BOthers0001193125-26-342406Aug 10, 2026 8:14 PM
1710-QQuarterly & Annual Report0001193125-26-342307Aug 10, 2026 8:00 PM
18144Insider Transaction0001970051-26-000018Aug 6, 2026 3:34 PM
19SCHEDULE 13GBeneficial Ownership Report0002012383-26-002507Jul 28, 2026 8:44 PM
208-KCurrent Report0001193125-26-308899Jul 20, 2026 8:00 PM
214Insider Transaction0001193125-26-297818Jul 7, 2026 12:00 AM
22144Insider Transaction0001970051-26-000017Jun 22, 2026 6:27 PM
238-KCurrent Report0001193125-26-274093Jun 17, 2026 8:00 PM
24SCHEDULE 13GBeneficial Ownership Report0000919574-26-003477May 15, 2026 8:20 PM
25SCHEDULE 13GBeneficial Ownership Report0000902664-26-002524May 15, 2026 8:16 PM
26SCHEDULE 13GBeneficial Ownership Report0000902664-26-002463May 15, 2026 12:16 PM
2710-QQuarterly & Annual Report0001193125-26-219327May 12, 2026 8:00 PM
283Insider Transaction0001193125-26-214909May 8, 2026 9:00 PM
298-KCurrent Report0001193125-26-203913May 4, 2026 8:00 PM
30ARSOthers0001193125-26-201367May 1, 2026 8:00 PM
31DEF 14AOthers0001193125-26-191429Apr 29, 2026 8:00 PM
32DEFA14AOthers0001193125-26-191426Apr 29, 2026 8:00 PM
33SCHEDULE 13GBeneficial Ownership Report0001193125-26-174461Apr 23, 2026 1:22 AM
34SCHEDULE 13GBeneficial Ownership Report0001193125-26-174454Apr 23, 2026 1:19 AM
358-KCurrent Report0001193125-26-163909Apr 20, 2026 8:00 PM
364Insider Transaction0001193125-26-138275Apr 1, 2026 9:30 PM
373Insider Transaction0001193125-26-138247Apr 1, 2026 9:24 PM
384Insider Transaction0001193125-26-124487Mar 25, 2026 10:09 PM
394Insider Transaction0001193125-26-124483Mar 25, 2026 10:08 PM
404Insider Transaction0001193125-26-124476Mar 25, 2026 10:05 PM
414Insider Transaction0001193125-26-124471Mar 25, 2026 10:03 PM
424Insider Transaction0001193125-26-124466Mar 25, 2026 10:01 PM
434Insider Transaction0001193125-26-124455Mar 25, 2026 9:57 PM
443Insider Transaction0001193125-26-124447Mar 25, 2026 9:52 PM
453Insider Transaction0001193125-26-124440Mar 25, 2026 9:49 PM
468-KCurrent Report0001193125-26-118699Mar 23, 2026 1:00 PM
47S-8Prospectus0001193125-26-117594Mar 20, 2026 8:00 PM
4810-KQuarterly & Annual Report0001193125-26-115922Mar 19, 2026 8:00 PM
498-KCurrent Report0001193125-26-099404Mar 10, 2026 12:00 PM
50SCHEDULE 13GBeneficial Ownership Report0001193125-26-096746Mar 6, 2026 9:43 PM
...

Damora Therapeutics, Inc. SEC Filings API

Pull Damora Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=DMRA&formtype=10-K,10-Q&api_key=YOUR_API_KEY